Two Sigma Advisers Reduces $140M in Centene Corporation ($CNC)
Key Points
- Two Sigma Advisers changed its Centene Corporation ($CNC) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $CNC is Buy and an average price target of $61.35.
- $CNC last traded around $63.54.
Two Sigma Advisers reduced its position in Centene Corporation ($CNC), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Centene Corporation after selling 2,196,692 shares during the quarter.
Centene Corporation ($CNC) Stock
Centene Corporation Earnings
Analysts Set New Price Targets
About Centene Corporation
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.